FIGO staging for carcinoma of the vulva, cervix, and corpus uteri.
FIGO Committee on Gynecologic Oncology.
Int J Gynaecol Obstet. 2014 May;125(2):97-8. doi: 10.1016/j.ijgo.2014.02.003. Epub 2014 Feb 22.
Carcinosarcoma of the corpus uteri (Malignant Mullerian Mixed Tumor): a case report in Yaounde (Cameroon).
Sando Z, Fouelifack FY, Fouogue JT, Fouedjio JH, Anoudem CE, Nangue C.
Pan Afr Med J. 2013 Dec 19;16:145. doi: 10.11604/pamj.2013.16.145.3497. eCollection 2013.
Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri.
Dvorská D, Škovierová H, Braný D, Halašová E, Danková Z.
Int J Mol Sci. 2019 Aug 5;20(15):3825. doi: 10.3390/ijms20153825.
Significance of uterine corpus tumor invasion in early-stage cervical cancer.
Matsuo K, Machida H, Blake EA, Takiuchi T, Mikami M, Roman LD.
Eur J Surg Oncol. 2017 Apr;43(4):725-734. doi: 10.1016/j.ejso.2017.01.017. Epub 2017 Feb 3.
Gynecological sarcomas.
DiSaia PJ, Pecorelli S.
Semin Surg Oncol. 1994 Sep-Oct;10(5):369-73. doi: 10.1002/ssu.2980100510.
Carcinoma of the corpus uteri.
Creasman WT, Odicino F, Maisonneuve P, Beller U, Benedet JL, Heintz AP, Ngan HY, Sideri M, Pecorelli S.
J Epidemiol Biostat. 2001;6(1):47-86.
Cancer of the corpus uteri.
Amant F, Mirza MR, Creutzberg CL.
Int J Gynaecol Obstet. 2012 Oct;119 Suppl 2:S110-7. doi: 10.1016/S0020-7292(12)60024-1.
Clinical and histopathological study of carcinoma of the corpus uteri.
Yajima A, Mori T, Nasu I, Kuramoto M, Wakisaka T, Suzuki M.
Tohoku J Exp Med. 1980 May;131(1):47-52. doi: 10.1620/tjem.131.47.
Secondary malignant involvement of gynecologic organs in radical cystectomy specimens in women: is it mandatory to remove these organs routinely?
Ali-El-Dein B, Abdel-Latif M, Mosbah A, Eraky I, Shaaban AA, Taha NM, Ghoneim MA.
J Urol. 2004 Sep;172(3):885-7. doi: 10.1097/01.ju.0000133986.29257.bf.
Prognostic parameters of endometrial carcinoma.
Prat J.
Hum Pathol. 2004 Jun;35(6):649-62. doi: 10.1016/j.humpath.2004.02.007.
